LIVE
Ethereum Reached Record Q1 On-Chain Users and Transaction Volume: ReportMorgan Stanley's Ethereum, Solana ETFs Target 0.14% FeeCME Sues CFTC Over Kalshi Perpetual FuturesKraken Launches In-App Trading for 2,500+ Solana TokensBitcoin Rodney Pleads Guilty in $1.8B HyperFund Fraud CaseCME to Sue CFTC Over Approval of Crypto Perpetual FuturesWorld Datacentre Summit Philippines 2026 Opens Sponsorship, Speaking, and Exhibition OpportunitiesARK Invest Buys $18.4 Million in Coinbase Shares Across Three ETFsWorld Datacentre Summit Malaysia 2026 Opens Sponsorship, Speaking, and Exhibition OpportunitiesKentucky Files Lawsuits Against Kalshi and PolymarketEthereum Reached Record Q1 On-Chain Users and Transaction Volume: ReportMorgan Stanley's Ethereum, Solana ETFs Target 0.14% FeeCME Sues CFTC Over Kalshi Perpetual FuturesKraken Launches In-App Trading for 2,500+ Solana TokensBitcoin Rodney Pleads Guilty in $1.8B HyperFund Fraud CaseCME to Sue CFTC Over Approval of Crypto Perpetual FuturesWorld Datacentre Summit Philippines 2026 Opens Sponsorship, Speaking, and Exhibition OpportunitiesARK Invest Buys $18.4 Million in Coinbase Shares Across Three ETFsWorld Datacentre Summit Malaysia 2026 Opens Sponsorship, Speaking, and Exhibition OpportunitiesKentucky Files Lawsuits Against Kalshi and Polymarket
Homepage/Altcoin News/Windtree Therapeutics Delisted from Nasdaq A...
ALTCOIN NEWS

Windtree Therapeutics Delisted from Nasdaq After BNB Focus

BY Solomon M.·2 MIN READ·AUGUST 21, 2025

Windtree Therapeutics Inc. will delist from Nasdaq due to BNB strategy and trading rules non-compliance.

Windtree Therapeutics Inc., a firm with a significant BNB allocation, will be delisted from Nasdaq on August 21, 2025, due to non-compliance with bid price rules.

KEY FINDINGS - EVIDENCE LEVEL: MULTI-SOURCE
1Key sections mapped in this report
0Internal references connected to related coverage
2External source domains cited in the article
2 minEstimated time to read the full report
Key Points:
  • Windtree Therapeutics Inc. is being delisted from Nasdaq.
  • Financial challenges persist despite investments in BNB.
  • The company will shift focus to over-the-counter markets.
windtree-therapeutics-delisted-from-nasdaq-after-bnb-focus
Windtree Therapeutics Delisted from Nasdaq After BNB Focus
MAGA

The delisting underscores challenges in corporate treasury shifts to crypto, causing Windtree’s stock to plummet without impacting broader BNB markets.

Windtree Therapeutics Inc. is being delisted from Nasdaq after failing to meet listing criteria. The company has heavily invested in Binance Coin (BNB), which hasn’t prevented its financial challenges. Trading is suspended on August 21, 2025. The delisting, confirmed by CEO Craig Fraser, shifts Windtree’s focus to over-the-counter markets. The transition does not affect day-to-day operations but could reduce stock liquidity for investors.

Craig Fraser, President & CEO, Windtree Therapeutics, – “The transition of its common stock to the OTC markets will not impact the company’s business operations. However, the OTC market generally has lower liquidity and less transparency compared to the Nasdaq, which would reduce the ease of buying or selling its stock” – SEC 8-K, August 20, 2025

Financial Challenges

Financial challenges have persisted despite a $700 million allocation to BNB assets. The company’s strategy to revamp its treasury around crypto does not gain the expected institutional support. Stock (WINT) fell 77% to $0.11. While the delisting affects Windtree directly, BNB prices have surged to highs above $880. This suggests market perception of the issue as company-specific rather than systemic within crypto sectors.

Regulatory Perspective

No significant regulatory actions or new policy changes emerged from the event. The situation remains under standard SEC and Nasdaq compliance measures. Experts note past precedents where companies failed in crypto pivots due to unchanged fundamentals. Meanwhile, no major on-chain data shifts for BNB arise, indicating primarily internal company impacts.

Disclaimer:

The content on The CCPress is provided for informational purposes only and should not be considered financial or investment advice. Cryptocurrency investments carry inherent risks. Please consult a qualified financial advisor before making any investment decisions.

SOURCE TRANSPARENCY
  • External Source - Referenced domain: buy.magacoinfinance.com
  • External Source - Referenced domain: sec.gov
  • Byline - Reported by Solomon M.
  • Coverage Desk - Primary editorial category: Altcoin News
  • Media Asset - Featured image served from the WordPress media library
Windtree Therapeutics Delisted from Nasdaq After BNB Focus | TheCCPress